Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
2 No-Brainer Stocks to Buy Right Now for Less than $55
03:30pm, Tuesday, 17'th May 2022 The Motley Fool
These companies have low share prices and high potential.
Is It Too Late to Buy AbbVie Stock?
03:23pm, Tuesday, 17'th May 2022 The Motley Fool
The bears think it's time to take profits and leave. But are they right?
Abbott, FDA reach deal to resume making baby formula at U.S. plant amid shortage
11:52am, Tuesday, 17'th May 2022 MarketWatch
Abbott Laboratories and the Food and Drug Administration reached a deal Monday to restart production of baby formula at a U.S. plant that has been shut down amid a recall of the product, which contrib
How the Infant Formula Recall Will Impact Abbott's Revenue
11:43am, Tuesday, 17'th May 2022 The Motley Fool
Big losses in the company's offerings for tiny people might not be as bad as they seem.
ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With the FDA
11:32am, Tuesday, 17'th May 2022
ABT stock is climbing on reports that Abbott has reached a deal to restart baby formula production at its Sturgis, Michigan plant. The post ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With
'Mother Like' Kim Jong-Un Personally Tastes Baby Formula To Ensure Quality: North Korea Mocks US Shortages
09:42am, Tuesday, 17'th May 2022 Benzinga
Taking a dig at the U.S. formula shortages, a bizarre news article from North Korean state media randomly claimed that Kim Jong Un personally oversaw the perfection of the nation's baby formula recipe
Nestle rushes shipments of baby formula from Netherlands, Switzerland to help U.S. shortages
09:16am, Tuesday, 17'th May 2022 MarketWatch
The Swiss food giant said it's taking additional steps to assist the struggle by U.S. parents to find baby formula.
US Baby Formula Crisis Could See Some Relief As FDA, Abbott Agree On Deal
07:46am, Tuesday, 17'th May 2022 Benzinga
The baby formula shortage that has morphed into a crisis in the U.S. could soon see some relief following an agreement between market leader Abbott Laboratories (NYSE: ABT) and the Food and Drug Admin
How the Infant Formula Recall Will Impact Abbott's Revenue
07:43am, Tuesday, 17'th May 2022
Big losses in the company's offerings for tiny people might not be as bad as they seem.
FDA and Abbott Nutrition reach deal to restart production of baby formula amid nationwide shortage
11:49pm, Monday, 16'th May 2022
Abbott said it could reopen its factory within two weeks, and then it would take six to eight more weeks for the products to reach stores.
Why there's a shortage of baby formula — and why health experts say it's dangerous to make your own formula
11:37pm, Monday, 16'th May 2022 MarketWatch
A baby formula shortage has been compounded by a product recall from baby-formula giant Abbott Nutrition and pandemic-induced supply-chain problems.
Abbott Spent $5B On Stock Buybacks Instead Of Fixing Its Baby Formula Factory
09:39pm, Monday, 16'th May 2022 Benzinga
The fear of not knowing where your child’s next meal comes from is something that no parent should face. But, because of a recall of Abbott Laboratories’ (NYSE: ABT) Similac and other popular baby
FDA reaches agreement with Abbott that could re-open formula plant
08:05pm, Monday, 16'th May 2022
CNBC's Valerie Castro joins Shep Smith to report on the nationwide baby formula shortage and the agreement reached with the FDA on a pathway to re-open the baby formula plant.
Abbott Strikes Deal With FDA To Reopen Baby Formula Plant At Center Of National Shortage
05:33pm, Monday, 16'th May 2022
It could take more than 10 weeks for Abbott Laboratories' baby formula to reappear on store shelves, the company said.
Abbott, FDA reach deal to resume making baby formula at U.S. plant amid shortage
05:09pm, Monday, 16'th May 2022
Abbott Laboratories and the Food and Drug Administration reached a deal Monday to restart production of baby formula at a U.S. plant that has been shut down amid a recall of the product, which contrib
